GLP1
Investing.com — The global obesity epidemic represents one of the most pressing public health challenges of our time. With nearly three-quarters of the U.S. population categorized as overweight or obese and similar trends emerging in countries like Mexico, Australia, and the United Kingdom (TADAWUL:), the burden of obesity-related health complications…
Investing.com — Weight-loss medications like the popular versions made by Denmark’s Novo Nordisk A/S (CSE:) and US peer Eli Lilly (NYSE:) are the “most compelling story within the healthcare sector,” analysts at Wells Fargo said. The GLP-1 class of drugs includes blockbuster brands like Novo’s Ozempic and Wegovy and Eli Lilly’s…
In 2019, Jennifer Brown was told she had high blood sugar and was on the verge of being diagnosed with type 2 diabetes. Her husband also had serious health issues — a history of cancer and a recent heart attack. While their daughter was about to finish high school, their…
